• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.

Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients

July 28, 2015
Janet Freeman-Daily
Janet Freeman-Daily

Janet Freeman-Daily is a writer, speaker, science geek and epatient with metastatic lung cancer. She uses her systems engineering background to translate the experience and science of lung cancer treatment and research into language other patients can understand. She comoderates the Lung Cancer Social Media (#LSCM) Chat on Twitter and blogs at www.grayconnections.wordpress.com.

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.

Related Content:

CURE TV
Theranostics 101: Combining Therapeutics and Diagnostics to Treat Prostate Cancer
An Inside Look at the Cancer Experience Registry and Its Findings on Anxiety in the Patient Population
Caregivers of Geriatric Patients with Cancer Are Under-Recognized But Critical Members of the Care Team
x